| Phase 2 |
| NCT06196697 |
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for… |
Gastric Adenocarcinoma |
Recruiting |
| NCT06196775 |
A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With… |
Hepatocellular Carcinoma |
Not Yet Recruiting |
| NCT06192680 |
Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in… |
Colorectal Cancer |
Not Yet Recruiting |
| NCT06304545 |
Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With… |
Rectal Cancer |
Not Yet Recruiting |
| NCT06306560 |
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of… |
Extensive-stage Small-cell Lung Cancer |
Not Yet Recruiting |
| NCT06389500 |
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally… |
Biliary Tract Cancer |
Not Yet Recruiting |
| NCT06508229 |
Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for… |
Esophageal Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT06648525 |
Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line… |
Intrahepatic Cholangiocarcinoma (Icc) |
Not Yet Recruiting |
| NCT06599216 |
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2… |
Breast Cancer |
Active, Not Recruiting |
| NCT07229872 |
A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in… |
Colorectal Cancer |
Not Yet Recruiting |
| NCT07471815 |
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An… |
Breast Cancer Triple Negative Breast Cancer |
Active, Not Recruiting |
| NCT07624201 |
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive… |
Muscle-Invasive Bladder Cancer (MIBC) |
Not Yet Recruiting |
| NCT07663071 |
Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as… |
Rectal Cancer Patients |
Active, Not Recruiting |
| NCT07682376 |
Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Active, Not Recruiting |
| NCT07687433 |
Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant… |
Rectal Cancer Patients |
Active, Not Recruiting |
| NCT07752550 |
Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast… |
Triple-Negative Breast Cancer (TNBC) |
Not Yet Recruiting |
| Phase 1/2 |
| NCT06513455 |
Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for… |
Pancreatic Cancer |
Not Yet Recruiting |
| NCT07161791 |
Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative… |
Breast Cancer |
Not Yet Recruiting |
| Not specified |
| NCT06365502 |
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE… |
Acute Coronary Syndrome (ACS) |
Recruiting |
| NCT06553430 |
Effects of an Aerobic Exercise Intervention on Core Symptoms, Executive Functioning, and… |
ADHD |
Recruiting |
| NCT04912518 |
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation… |
ST-segment Elevation Myocardial Infarction (STEMI) |
Recruiting |
| NCT06154395 |
Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial… |
Intravascular Imaging and Microvascular Obstruction |
Recruiting |
| NCT06016608 |
An Imaging Study of Polyvascular Disease |
Polyvascular Disease |
Recruiting |
| NCT06348992 |
ACT Combined Yoga for Parental Burnout in Parents with Autistic Children |
Autism Spectrum Disorder |
Recruiting |
| NCT07002801 |
Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and… |
Gastrointestinal Disease |
Recruiting |